1167P SILVELUL SCORE: An original or modified immunohistochemical score (IPS or mIPS) in patients (pts) with pancreatic neuroendocrine tumours (PanNET) treated with everolimus or CAPTEM.

MLA

Viudez, A., et al. “1167P SILVELUL SCORE: An Original or Modified Immunohistochemical Score (IPS or MIPS) in Patients (Pts) with Pancreatic Neuroendocrine Tumours (PanNET) Treated with Everolimus or CAPTEM.” Annals of Oncology, vol. 31, Sept. 2020, p. S775. EBSCOhost, https://doi.org/10.1016/j.annonc.2020.08.1380.

APA

Viudez, A., Crespo, G., Gómez-Dorronsoro, M. L., Custodio, A., Benavent, M., Paredes, B. G., Hernando, J., Alonso-Orduna, V., Goñi, S., López, C., Jimenez-Fonseca, P., González, I., López-San Vicente, B., García, I. S., Hernandez, I., Carmona, A., Sanz, J. P., Ricarte, L. L., Marin, J., & De Jesus-Acosta, A. (2020). 1167P SILVELUL SCORE: An original or modified immunohistochemical score (IPS or mIPS) in patients (pts) with pancreatic neuroendocrine tumours (PanNET) treated with everolimus or CAPTEM. Annals of Oncology, 31, S775. https://doi.org/10.1016/j.annonc.2020.08.1380

Chicago

Viudez, A., G. Crespo, M.L. Gómez-Dorronsoro, A. Custodio, M. Benavent, B. García Paredes, J. Hernando, et al. 2020. “1167P SILVELUL SCORE: An Original or Modified Immunohistochemical Score (IPS or MIPS) in Patients (Pts) with Pancreatic Neuroendocrine Tumours (PanNET) Treated with Everolimus or CAPTEM.” Annals of Oncology 31 (September): S775. doi:10.1016/j.annonc.2020.08.1380.